Kristen Monaco is a Senior Staff Writer at MedPage Today. She specializes in medicine and healthcare, with a focus on topics such as mental health care, endocrinology, psychiatry, public health, and healthcare technology. Kristen's work has been featured in Knowledia, MSN, and MedPage Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kristen Monaco's articles primarily focus on healthcare and pharmaceuticals, with a strong emphasis on citing data. She covers a wide range of topics including mental health, medical research, diabetes, obesity, and kidney disease. If you have new scientific findings or access to relevant data in these areas, she may be interested in your insights.
As her coverage does not specify any geographic focus and encompasses global issues related to healthcare and pharmaceuticals, consider reaching out with international perspectives or studies that can provide valuable insights into the topics covered in her articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .
— Two-thirds of websites did not require clinician interaction before a prescription
By: Kristen Monaco
Americans' use of GLP-1 injectables for weight-loss opens in a new tab or window reached a record high, nearly quadrupling since 2024, according to a national Gallup poll.
Focal segmental glomerulosclerosis (FSGS), a rare and aggressive kidney disease characterized by scarring of the glomeruli, has no known cure but treatment options are expanding.
By: Kristen Monaco
— News and commentary from the psychiatry world Two executives from the San Francisco-based telehealth provider Done Global were sentenced
Despite treatment advances, kidney disease burden remained unchanged over the past decade
The prevalence of chronic kidney disease (CKD) in the U.S. was generally stable over the past decade, but the underlying diagnoses driving the
Phase III data supported setmelanotide's recent label expansion in acquired hypothalamic obesity
Kristen Monaco Treatment with setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, led to significant reductions in body mass
By: Kristen Monaco
— Increases in serum creatinine similar to patients who received usual care Key Takeaways
By: Kristen Monaco
— No difference in insulin discontinuation rates seen among three glucose-lowering classes
